Eli Lilly’s new pill could offer an easier path to weight loss for needle-averse patients

Patrik Jonsson, the head of pharmaceutical behemoth Eli Lilly, said he expects orforgilpron to be available as early as next year, if approved by regulators.

Weight-loss drug Mounjaro will be rolled out to a quarter of a million NHS patients. But leading experts tell Rebecca Thomas and Alicja Hagiopan that weight-loss jabs alone will…

Eli Lilly’s new pill could offer an easier path to weight loss for needle-averse patients